Tenon Medical Q3 EPS $(1.46) Beats $(2.80) Estimate, Sales $944.00K Miss $1.07M Estimate
Portfolio Pulse from totan@benzinga.com
Tenon Medical (NASDAQ:TNON) reported Q3 earnings with a loss of $(1.46) per share, outperforming the $(2.80) estimate, marking a 48.23% improvement from the previous year. However, sales of $944.00K fell short of the $1.07M estimate, despite being a 353.85% increase from the same period last year.
November 14, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Tenon Medical reported better-than-expected Q3 EPS at $(1.46) vs. $(2.80) estimate but missed revenue estimates with $944K vs. $1.07M expected.
The mixed results with an EPS beat and a sales miss could lead to a neutral short-term impact on TNON's stock price. Investors may weigh the positive earnings surprise against the revenue shortfall, leading to uncertain price movement.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100